Astigmatism Correction Carl Zeiss Case Studies Empowering Providers with the Multimodal Maestro2 Extending dosing of anti-VEGF High-Frequency Deep Sclerotomy A MIGS Procedure for Mild-to-Moderate Glaucoma iCare COMPASS Automated Perimeter Optimizing clinical care and practice efficiency with multimodal Triton™ imaging

Astigmatism Correction Carl Zeiss Case Studies Empowering Providers with the Multimodal Maestro2 Extending dosing of anti-VEGF High-Frequency Deep Sclerotomy A MIGS Procedure for Mild-to-Moderate Glaucoma iCare COMPASS Automated Perimeter Optimizing clinical care and practice efficiency with multimodal Triton™ imaging

View More Cataract & Refractive Cornea Gene Therapy Glaucoma Inflammation & Infection Paediatrics Retina

Cataract & Refractive Cornea Gene Therapy Glaucoma Inflammation & Infection Paediatrics Retina

Medical World News

Eyeviews Medical World News Podcasts Rapid Readouts Viewpoints

Digital Edition

Supplements And Featured Publications

Digital Edition Supplements And Featured Publications

Conference Coverage

Conference Listing

Sponsored Resources

Zeiss Case Studies

Sponsored Resources Zeiss Case Studies

Print Subscription

eNewsletter Print Subscription

Advertise
Editorial Info
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Information

© 2022 MJH Life Sciences and Opthalmology Times Europe. All rights reserved.

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

Astigmatism Correction
Carl Zeiss Case Studies
Empowering Providers with the Multimodal Maestro2
Extending dosing of anti-VEGF
High-Frequency Deep Sclerotomy A MIGS Procedure for Mild-to-Moderate Glaucoma
iCare COMPASS Automated Perimeter
Optimizing clinical care and practice efficiency with multimodal Triton™ imaging

ClinicalSee All >

Cataract & Refractive
Cornea
Gene Therapy
Glaucoma
Inflammation & Infection
Paediatrics
Retina

Advertise
Editorial Info
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Information

© 2022 MJH Life Sciences^™ and Opthalmology Times Europe. All rights reserved.

OSC is a rare cancer in the UK

January 16, 2013

Ocular sebaceous carcinoma (OSC) has been confirmed as a rare cancer in the UK, claims a recent study.

Related Content:

Weekly review in ophthalmology: 14 May - 20 May

Weekly review in ophthalmology: 14 May - 20 May

Approaching pharmaceutical treatment for cataracts

Approaching pharmaceutical treatment for cataracts

Strategic alliance combines resources to develop treatment option for dry eye syndrome

Strategic alliance combines resources to develop treatment option for dry eye syndrome